 |
|
|
|
|
|
|
| Article 1 to 6 out of 6 concerning Innogenetics Group
|
-
Innogenetics achieves CE mark for new human papillomavirus (HPV) genotyping test
(04 Jun 2008)
Innogenetics announced that it has received CE marking for its new and expanded HPV genotyping test, the INNO-LiPA HPV Genotyping Extra. The new generation kit allows the genotyping of 28 different HPV genotypes, of which 18 are high-risk types for ...
-
Innogenetics concludes settlement and licensing agreement in the field of Hepatitis C diagnostics
(19 Oct 2007)
Innogenetics announced an agreement with Novartis on major licensing terms in the field of Hepatitis C Virus (HCV) diagnostics. According to the license agreement, Novartis grants Innogenetics a license to its Hepatitis C patent rights in the field ...
-
Innogenetics signs exclusive agreement with AdnaGen to develop and commercialize new multiplex oncology tests
(15 Oct 2007)
Innogenetics NV and AdnaGen AG announced that they have entered into an exclusive worldwide license agreement to develop and commercialize new multiplex tests in the field of oncology. The diagnostic tests rely on circulating tumour cells in ...
-
Innogenetics presents research results for first Alzheimer biomarker test in blood
(14 Jun 2007)
At the Alzheimer's Association's International Conference on Prevention of Dementia, Innogenetics presented research results with the first commercial blood test for beta-amyloid protein. Beta-amyloid is one of the potential biomarkers for ...
-
Innogenetics receives unanimous verdict against Abbott
(05 Sep 2006)
On Friday, September 1, 2006, a Jury unanimously upheld the validity of Innogenetics' patent, U.S. Patent No. 5,846,704 ("the '704 patent"), which claims a method of genotyping the Hepatitis C Virus ("HCV"). The dispute began in September 2005 when ...
-
Innogenetics acquires full PCR license from Roche Diagnostics
(20 Oct 2005)
Innogenetics and Roche Diagnostics announced that they have signed an agreement by which Roche has granted Innogenetics a full, worldwide license for the use of its patented polymerase chain reaction (PCR) technology in the development and ...
|
|
|
|
|
Top
analytica
analytica China
analytica Vietnam
analytica Anacon